Skip to content

PCV vs VCV in Low-Flow Anesthesia

Pressure-Controlled Versus Volume-Controlled Ventilation in Low-Flow Anesthesia: A Randomized Controlled Trial on Intraoperative Respiratory Mechanics and Postoperative Pulmonary Function

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07305129
Enrollment
40
Registered
2025-12-26
Start date
2023-08-06
Completion date
2023-12-03
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ASA Class I/II Patients, General Anesthetic, Low Flow Anesthesia

Keywords

low-flow anesthesia, pressure-controlled ventilation, volume-controlled ventilation, respiratory mechanics, peak inspiratory pressure, pulmonary function

Brief summary

The aim of this observational study is to investigate the effects of ventilation modes on intraoperative and postoperative lung functions in patients under general anesthesia. This study aimed to compare the effects of low-flow anesthesia on intraoperative respiratory mechanics and early postoperative pulmonary function between PCV and VCV in ASA I-II adult patients.

Detailed description

Studies comparing the effects of pressure-controlled ventilation (PCV) and volume-controlled ventilation (VCV) on lung function under low-flow conditions are limited. In this study, the effects of PCV and VCV on intraoperative respiratory mechanics and early postoperative pulmonary function were investigated during low-flow anesthesia in ASA I-II adult patients undergoing routine anesthesia procedures.

Interventions

None listed

Sponsors

HULYA TOPCU, MD
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

\- age 18-65 years and American Society of Anesthesiologists (ASA) physical status I-II.

Exclusion criteria

* morbid obesity (BMI \> 35 kg/m²), * scoliosis or thoracic deformity, * restrictive or obstructive lung disease, * prior thoracic or upper abdominal surgery, * history of major thoracic trauma or congenital chest wall anomaly, * active smoking or chronic use of corticosteroids, * β-agonists, bronchodilators, or antihistamines, * anticipated difficult airway * severe hypoxemia (SpO₂ \< 90%) during induction.

Design outcomes

Primary

MeasureTime frameDescription
Mean Ppeak (cmH₂O) at each time point; between-group difference.From post-intubation baseline until 30 minutes after initiation of low-flow anesthesia (approximately 45 minutes total).Peak inspiratory pressure will be measured using the anesthesia workstation's built-in pressure monitoring system. Ppeak (cmH₂O) values will be automatically recorded at predefined time points: baseline after intubation, before low-flow transition, and 5, 10, 15, and 30 minutes after transition to low-flow anesthesia. Group comparisons will be reported as mean ± SD and analyzed for intergroup differences.

Secondary

MeasureTime frameDescription
Change in inspiratory score (number of balls raised).Baseline to 30 minutes after initiation of low-flow anesthesia and Preoperative baseline and postoperative 1 hourMean airway pressure will be measured continuously by the anesthesia machine. Values will be recorded at the same predefined time points as Ppeak. Data will be reported as mean ± SD. Dynamic compliance (mL/cmH₂O) will be calculated using the ventilator's automated measurement system (tidal volume / (Ppeak - PEEP)). Values will be recorded at identical intraoperative time points. Data will be reported as mean ± SD. Inspiratory effort will be assessed using the Triflo incentive spirometer by recording the number of balls elevated on a single maximal inspiratory attempt (range: 0-3). Measurements will be taken preoperatively and 1 hour postoperatively in the recovery unit.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026